Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bestrophin Blocking Peptide (AC1221)
Cat.#: ACPP-1221
Specifications
Despition Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1625 Human POMC Protein (AC1625) 2 µg inquiry ACPP-1603 Human TIMP1 Protein (AC1603) 2 µg inquiry ACPP-1188 GRIK1 Blocking Peptide (AC1188) 250 µg inquiry ACPP-1622 Human DLK1 Protein (AC1622) 2 µg inquiry ACPP-1459 Human Midkine Protein, His (AC1459) 5 µg inquiry ACPP-1668 Human BDNF Protein, His (AC1668) 5 µg inquiry ACPP-1237 CRMP1 Blocking Peptide (AC1237) 250 µg inquiry ACPP-1385 Human TGFBI Protein (AC1385) 5 µg inquiry ACPP-1395 Human PINK1 Protein (AC1395) 5 µg inquiry ACPP-1554 Human Human FGF1 (Active) Protein (AC1554) 500U inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket